Adaptive Biotechnologies Corporation revenue breakdown overview

Adaptive Biotechnologies Corporation revenue for the last year amounted to 170.28 M USD, the most of which — 102.74 M USD — came from its highest performing source at the moment, Minimal Residual Disease - Service, the year earlier bringing 81.14 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Adaptive Biotechnologies Corporation 170.28 M USD, and the year before that — 185.31 M USD.